Clinic
SJHMC Physician Services
SJHMC Physician Services was paid $46.65M by Medicaid between Jan 2018 and Dec 2024, across 257 billing codes. Its largest line is 99233, hospital visit by a doctor, follow-up day (complex) — 14% of everything it billed.
33Billing provider infoSJHMC PHYSICIAN SERVICES
PHOENIX, AZ 85013
PHOENIX, AZ 85013
33aNPI1326098005assigned 05/11/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$46.65M
24GClaims995,373
24DCodes billed257
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Arizona
Rank by total paid#5 of 76
Median peer was paid$899K
This provider vs. median52×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 147,238 | $7.78M | |
| 2019 | 153,138 | $7.56M | |
| 2020 | 137,808 | $5.40M | |
| 2021 | 145,419 | $6.50M | |
| 2022 | 146,747 | $6.65M | |
| 2023 | 152,018 | $6.96M | |
| 2024incomplete | 113,005 | $5.80M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 14% | 89,770 | 40,176 | $6.32M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 93,709 | 88,407 | $6.01M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.3% | 74,584 | 67,377 | $3.42M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.4% | 40,454 | 39,698 | $2.98M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 5.3% | 5,235 | 4,587 | $2.50M |
| 99223 | Prolong inpt eval add15 m | 4.9% | 17,836 | 17,484 | $2.30M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.5% | 33,379 | 16,975 | $1.63M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 3.4% | 10,979 | 4,475 | $1.58M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 16,863 | 15,791 | $1.56M |
| 99239 | Hospital discharge day management, more than 30 minutes | 2.6% | 16,311 | 16,045 | $1.20M |
| 71045 | Radiologic examination, chest; single view | 2.4% | 162,801 | 128,621 | $1.14M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.3% | 17,510 | 17,088 | $1.06M |
245 more codes
| 99215 | Doctor's office visit, returning patient (complex) | 1.9% | 11,464 | $872K |
| 59025 | Fetal non-stress test | 1.8% | 26,664 | $844K |
| 95951 | 1.7% | 3,169 | $771K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.6% | 9,046 | $761K |
| 95720 | 1.4% | 3,905 | $634K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.3% | 9,444 | $604K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.3% | 8,671 | $593K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 11,028 | $559K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 4,884 | $502K |
| J2350 | Injection, ocrelizumab, 1 mg | 1.0% | 27 | $483K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 5,788 | $366K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 35,312 | $324K |
| 76801 | <1% | 3,833 | $291K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 4,679 | $253K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 9,585 | $245K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 2,196 | $229K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 4,086 | $224K |
| 99220 | <1% | 2,005 | $214K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 4,099 | $211K |
| 99460 | <1% | 2,728 | $208K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 4,689 | $202K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,687 | $183K |
| 76830 | Ultrasound, transvaginal | <1% | 2,907 | $178K |
| 74018 | <1% | 26,969 | $177K | |
| 93970 | <1% | 6,610 | $175K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,772 | $165K |
| 76820 | <1% | 4,467 | $159K | |
| 31231 | <1% | 1,094 | $150K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 29,392 | $149K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,073 | $144K |
| 64642 | <1% | 1,356 | $143K | |
| 64615 | <1% | 1,346 | $140K | |
| 74183 | <1% | 1,898 | $135K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,263 | $131K |
| 71250 | <1% | 3,746 | $129K | |
| 64643 | <1% | 1,066 | $112K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 3,463 | $110K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,395 | $108K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,775 | $107K |
| 93971 | <1% | 5,774 | $104K | |
| 49083 | <1% | 1,270 | $100K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,263 | $94K |
| 64400 | <1% | 863 | $90K | |
| 99255 | <1% | 555 | $89K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,804 | $88K |
| 95874 | <1% | 1,482 | $86K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,695 | $76K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,781 | $76K |
| D8670 | Periodic orthodontic treatment visit | <1% | 1,113 | $71K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,213 | $71K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,435 | $69K |
| 76506 | <1% | 1,816 | $60K | |
| 92526 | <1% | 689 | $59K | |
| 64405 | <1% | 1,151 | $54K | |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 195 | $54K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,013 | $53K |
| 77014 | <1% | 1,784 | $51K | |
| 92083 | <1% | 986 | $51K | |
| 20610 | <1% | 1,016 | $49K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 1,372 | $48K |
| 94010 | <1% | 4,375 | $46K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,761 | $46K |
| 95718 | <1% | 415 | $44K | |
| 99152 | <1% | 4,662 | $43K | |
| 95938 | <1% | 1,088 | $42K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 778 | $41K |
| 73562 | <1% | 4,978 | $41K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,885 | $40K |
| 99221 | <1% | 622 | $40K | |
| 90686 | <1% | 8,620 | $38K | |
| 76775 | <1% | 1,603 | $38K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 491 | $35K |
| 96161 | <1% | 11,002 | $35K | |
| 64612 | <1% | 504 | $34K | |
| 93976 | <1% | 844 | $33K | |
| 99254 | <1% | 223 | $33K | |
| 95941 | <1% | 123 | $32K | |
| 99205 | Prolong outpt/office vis | <1% | 272 | $31K |
| 64646 | <1% | 317 | $29K | |
| 73630 | <1% | 3,893 | $28K | |
| 73030 | <1% | 3,505 | $28K | |
| 20553 | <1% | 1,252 | $27K | |
| 99177 | <1% | 932 | $24K | |
| 99497 | <1% | 593 | $23K | |
| 72100 | <1% | 2,219 | $21K | |
| 93308 | <1% | 1,197 | $20K | |
| 92133 | <1% | 723 | $18K | |
| 73130 | <1% | 2,121 | $17K | |
| 96156 | <1% | 185 | $16K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 394 | $16K |
| 94729 | <1% | 1,848 | $15K | |
| 99356 | <1% | 311 | $15K | |
| 76818 | <1% | 158 | $14K | |
| 92250 | <1% | 283 | $14K | |
| 64616 | <1% | 347 | $14K | |
| 76821 | <1% | 226 | $14K | |
| 76813 | <1% | 128 | $13K | |
| 73610 | <1% | 1,644 | $12K | |
| 70250 | <1% | 1,415 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,582 | $12K |
| 73590 | <1% | 1,661 | $11K | |
| 76642 | <1% | 360 | $11K | |
| 99217 | <1% | 239 | $11K | |
| 96132 | <1% | 97 | $10K | |
| 64483 | <1% | 43 | $10K | |
| 92522 | <1% | 111 | $10K | |
| 72040 | <1% | 1,012 | $10K | |
| 96139 | <1% | 82 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 202 | $9K |
| 94618 | <1% | 633 | $9K | |
| 43264 | <1% | 52 | $8K | |
| 99442 | <1% | 319 | $8K | |
| 73502 | <1% | 974 | $8K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 39 | $7K |
| 72170 | <1% | 1,006 | $7K | |
| 93000 | <1% | 596 | $7K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 117 | $7K |
| 92524 | <1% | 81 | $6K | |
| 72197 | <1% | 82 | $6K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 53 | $6K |
| 97802 | <1% | 67 | $6K | |
| 62370 | <1% | 130 | $6K | |
| 90837 | Psychotherapy session, about an hour | <1% | 52 | $6K |
| 96133 | <1% | 68 | $6K | |
| 95251 | <1% | 220 | $5K | |
| 81025 | <1% | 856 | $5K | |
| 99463 | <1% | 67 | $5K | |
| 96116 | <1% | 67 | $5K | |
| 77427 | <1% | 34 | $5K | |
| 93321 | <1% | 950 | $5K | |
| 73110 | <1% | 348 | $5K | |
| 96119 | <1% | 44 | $5K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 58 | $4K |
| 01961 | <1% | 17 | $4K | |
| 72082 | <1% | 350 | $4K | |
| 31575 | <1% | 44 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 348 | $4K |
| 94726 | <1% | 416 | $4K | |
| 77300 | <1% | 30 | $4K | |
| 91010 | <1% | 64 | $3K | |
| 77080 | <1% | 518 | $3K | |
| 99292 | <1% | 42 | $3K | |
| 97803 | <1% | 70 | $3K | |
| 92540 | <1% | 43 | $3K | |
| 73700 | <1% | 80 | $3K | |
| 77334 | <1% | 24 | $3K | |
| D0367 | <1% | 12 | $3K | |
| 93975 | <1% | 69 | $3K | |
| 76536 | <1% | 115 | $3K | |
| 74220 | <1% | 137 | $3K | |
| 74019 | <1% | 232 | $3K | |
| 96150 | <1% | 60 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 118 | $2K |
| 96138 | <1% | 82 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 19 | $2K |
| 20611 | <1% | 36 | $2K | |
| 43235 | <1% | 26 | $2K | |
| 72110 | <1% | 67 | $2K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 27 | $2K |
| 99253 | <1% | 27 | $2K | |
| 88720 | <1% | 447 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 235 | $2K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 15 | $2K |
| 76937 | <1% | 196 | $2K | |
| 73560 | <1% | 285 | $2K | |
| 99498 | <1% | 48 | $2K | |
| 90656 | <1% | 309 | $2K | |
| 96154 | <1% | 34 | $2K | |
| 96127 | <1% | 290 | $2K | |
| 76770 | <1% | 52 | $2K | |
| 99462 | <1% | 47 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $1K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 43 | $1K |
| 90474 | <1% | 72 | $1K | |
| 96118 | <1% | 15 | $1K | |
| 64644 | <1% | 15 | $1K | |
| 72050 | <1% | 44 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 24 | $1K |
| 92557 | <1% | 40 | $1K | |
| 74022 | <1% | 67 | $1K | |
| 97161 | <1% | 14 | $990.68 | |
| 95822 | <1% | 16 | $918.28 | |
| 73090 | <1% | 113 | $910.62 | |
| 95813 | <1% | 12 | $906.42 | |
| 93298 | <1% | 79 | $895.53 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 66 | $877.52 |
| 76376 | <1% | 122 | $843.71 | |
| 95819 | <1% | 13 | $759.97 | |
| 99441 | <1% | 98 | $707.93 | |
| 85610 | <1% | 283 | $656.15 | |
| 82962 | <1% | 281 | $612.39 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 35 | $597.77 |
| 96380 | <1% | 37 | $577.54 | |
| 90480 | <1% | 29 | $574.32 | |
| 95816 | <1% | 13 | $552.32 | |
| 73600 | <1% | 26 | $541.39 | |
| 73564 | <1% | 13 | $470.59 | |
| 77001 | <1% | 41 | $465.09 | |
| D9430 | <1% | 16 | $455.55 | |
| 99459 | <1% | 17 | $447.51 | |
| 77012 | <1% | 13 | $438.18 | |
| 90670 | <1% | 5,984 | $405.91 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 939 | $396.46 |
| 73080 | <1% | 59 | $395.36 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 30 | $386.49 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 100 | $385.51 |
| 94060 | <1% | 54 | $377.43 | |
| 76981 | <1% | 17 | $353.05 | |
| 72084 | <1% | 25 | $333.45 | |
| 71101 | <1% | 24 | $303.41 | |
| 96160 | <1% | 62 | $297.77 | |
| 73120 | <1% | 17 | $297.41 | |
| 92537 | <1% | 12 | $294.46 | |
| 90677 | <1% | 697 | $270.92 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 209 | $244.01 |
| 90723 | <1% | 3,974 | $230.88 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13 | $218.79 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 45 | $196.45 |
| 99188 | <1% | 16 | $192.56 | |
| 73620 | <1% | 28 | $174.51 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 272 | $171.47 |
| 90680 | <1% | 4,231 | $167.86 | |
| 81003 | <1% | 77 | $145.62 | |
| 99443 | <1% | 15 | $142.28 | |
| 90648 | <1% | 6,020 | $139.96 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 115 | $106.57 |
| 73552 | <1% | 12 | $105.86 | |
| 92552 | <1% | 13 | $102.63 | |
| G0008 | Administration of influenza virus vaccine | <1% | 76 | $33.21 |
| 80305 | <1% | 235 | $31.26 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 16 | $0.12 |
| 90707 | 0% | 602 | $0.00 | |
| G8421 | Bmi not documented and no reason is given | 0% | 569 | $0.00 |
| 90633 | 0% | 845 | $0.00 | |
| 90700 | 0% | 14 | $0.00 | |
| 90685 | 0% | 14 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 2,379 | $0.00 |
| 99024 | 0% | 1,476 | $0.00 | |
| 90716 | 0% | 603 | $0.00 | |
| 90381 | 0% | 32 | $0.00 | |
| 2016F | 0% | 27 | $0.00 | |
| 90698 | 0% | 115 | $0.00 | |
| 90651 | 0% | 14 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 49 | $0.00 |
| 90696 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACKSON, JEFFREY (CHIEF FINANCIAL OFFICER)
Parent organizationDIGNITY HEALTH
| Provider | Location | Paid |
|---|---|---|
| Dignity Health | Glendale, AZ | $5.61M |
| Dignity Health | Litchfield Park, AZ | $4.45M |
| Jackson Pediatric Dentistry of Summerville | Summerville, SC | $443K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.